Diaz, M., & Pan, P. C. (2025). Management of Low-Grade Gliomas. The Cancer Journal, 31(1). https://doi.org/10.1097/ppo.0000000000000760

Zhang, C., Zhao, N., Khan, R., Hung, M., Zhang, C., Wang, S., Wang, T. J. C., & Lin, C. (2024). The prognostic significance of androgen receptor expression in gliomas. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-72284-4

Liu, J., Cao, S., Imbach, K. J., Gritsenko, M. A., Lih, T.-S. M., Kyle, J. E., Yaron-Barir, T. M., Binder, Z. A., Li, Y., Strunilin, I., Wang, Y.-T., Tsai, C.-F., Ma, W., Chen, L., Clark, N. M., Shinkle, A., Naser Al Deen, N., Caravan, W., Houston, A., … Ding, L. (2024). Multi-scale signaling and tumor evolution in high-grade gliomas. Cancer Cell, 42(7), 1217-1238.e19. https://doi.org/10.1016/j.ccell.2024.06.004

Arrillaga-Romany, I., Lassman, A., McGovern, S. L., Mueller, S., Nabors, B., van den Bent, M., Vogelbaum, M. A., Allen, J. E., Melemed, A. S., Tarapore, R. S., Wen, P. Y., & Cloughesy, T. (2024). ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro-Oncology, 26(Supplement_2), S173–S181. https://doi.org/10.1093/neuonc/noae031

Liu, Z., Mela, A., Argenziano, M. G., Banu, M. A., Furnari, J., Kotidis, C., Sperring, C. P., Humala, N., Mahajan, A., Bruce, J. N., Canoll, P., & Sims, P. A. (2024). Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma. Journal of Neurosurgery, 140(4), 968–978. https://doi.org/10.3171/2023.7.jns23122

Tazhibi, M., McQuillan, N., Wei, H.-J., Gallitto, M., Bendau, E., Webster Carrion, A., Berg, X., Kokossis, D., Zhang, X., Zhang, Z., Jan, C.-I., Mintz, A., Gartrell, R. D., Syed, H. R., Fonseca, A., Pavisic, J., Szalontay, L., Konofagou, E. E., Zacharoulis, S., & Wu, C.-C. (2024). Focused ultrasound-mediated blood–brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma. Journal of Translational Medicine, 22(1). https://doi.org/10.1186/s12967-024-05096-9

Tzaridis, T., & Wechsler-Reya, R. J. (2024). Just a spoonful of metformin helps the medicine go down. Journal of Clinical Investigation, 134(6). https://doi.org/10.1172/jci179144

Padilla, O., Minns, H. E., Wei, H.-J., Fan, W., Webster-Carrion, A., Tazhibi, M., McQuillan, N. M., Zhang, X., Gallitto, M., Yeh, R., Zhang, Z., Hei, T. K., Szalontay, L., Pavisic, J., Tan, Y., Deoli, N., Garty, G., Garvin, J. H., Canoll, P. D., … Gartrell, R. D. (2024). Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma. International Journal of Radiation Oncology*Biology*Physics, 119(4), 1248–1260. https://doi.org/10.1016/j.ijrobp.2024.01.219

Arrillaga-Romany, I., Gardner, S. L., Odia, Y., Aguilera, D., Allen, J. E., Batchelor, T., Butowski, N., Chen, C., Cloughesy, T., Cluster, A., de Groot, J., Dixit, K. S., Graber, J. J., Haggiagi, A. M., Harrison, R. A., Kheradpour, A., Kilburn, L. B., Kurz, S. C., Lu, G., … Wen, P. Y. (2024). ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma. Journal of Clinical Oncology, 42(13), 1542–1552. https://doi.org/10.1200/jco.23.01134

Duffau, H., Berger, M., Brastianos, P. K., Sanai, N., Mandonnet, E., & McKhann, G. M. (2024). Introduction: Contemporary management of low-grade gliomas: from tumor biology to the patient’s quality of life. Neurosurgical Focus, 56(2), E1. https://doi.org/10.3171/2023.11.focus23731

Wang, L., Higgins, D., Delgardo, M., Chang, C., Hamberger, M. J., & McKhann, G. M. (2024). Awake intraoperative mapping for the prevention of amusia. Neurosurgical Focus, 56(2), E8. https://doi.org/10.3171/2023.11.focus23600

Sprinzen, L., Garcia, F., Mela, A., Lei, L., Upadhyayula, P., Mahajan, A., Humala, N., Manier, L., Caprioli, R., Quiñones-Hinojosa, A., Casaccia, P., & Canoll, P. (2024). EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor. Cells, 13(3), 219. https://doi.org/10.3390/cells13030219

Giacomini, G., Piquet, S., Chevallier, O., Dabin, J., Bai, S.-K., Kim, B., Siddaway, R., Raught, B., Coyaud, E., Shan, C.-M., Reid, R. J. D., Toda, T., Rothstein, R., Barra, V., Wilhelm, T., Hamadat, S., Bertin, C., Crane, A., Dubois, F., … Polo, S. E. (2024). Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors. Nucleic Acids Research, 52(5), 2372–2388. https://doi.org/10.1093/nar/gkad1257

Kinslow, C. J., Siegelin, M. D., Iwamoto, F. M., Gallitto, M., Neugut, A. I., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). MGMT promoter methylation in 1p19q-intact gliomas. Journal of Neuro-Oncology, 166(1), 73–78. https://doi.org/10.1007/s11060-023-04515-z

Dmello, C., Zhao, J., Chen, L., Gould, A., Castro, B., Arrieta, V. A., Zhang, D. Y., Kim, K.-S., Kanojia, D., Zhang, P., Miska, J., Yeeravalli, R., Habashy, K., Saganty, R., Kang, S. J., Fares, J., Liu, C., Dunn, G., Bartom, E., … Sonabend, A. M. (2023). Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-36878-2

Kinslow, C. J., Cheng, S. K., & Wang, T. J. C. (2023). MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas—Reply. JAMA Oncology, 9(12), 1735. https://doi.org/10.1001/jamaoncol.2023.4754

Al-Dalahmah, O., Argenziano, M. G., Kannan, A., Mahajan, A., Furnari, J., Paryani, F., Boyett, D., Save, A., Humala, N., Khan, F., Li, J., Lu, H., Sun, Y., Tuddenham, J. F., Goldberg, A. R., Dovas, A., Banu, M. A., Sudhakar, T., Bush, E., … Canoll, P. (2023). Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-38186-1

Upadhyayula, P. S., Higgins, D. M., Mela, A., Banu, M., Dovas, A., Zandkarimi, F., Patel, P., Mahajan, A., Humala, N., Nguyen, T. T. T., Chaudhary, K. R., Liao, L., Argenziano, M., Sudhakar, T., Sperring, C. P., Shapiro, B. L., Ahmed, E. R., Kinslow, C., Ye, L. F., … Canoll, P. (2023). Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-36630-w

Koschmann, C., Al-Holou, W. N., Alonso, M. M., Anastas, J., Bandopadhayay, P., Barron, T., Becher, O., Cartaxo, R., Castro, M. G., Chung, C., Clausen, M., Dang, D., Doherty, R., Duchatel, R., Dun, M., Filbin, M., Franson, A., Galban, S., Garcia Moure, M., … Venneti, S. (2024). A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell, 42(1), 1–5. https://doi.org/10.1016/j.ccell.2023.11.002

Kinslow, C. J., Rae, A. I., Taparra, K., Kumar, P., Siegelin, M. D., Grinband, J., Gill, B. J. A., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Horowitz, D. P., Kachnic, L. A., Neugut, A. I., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas. Clinical Cancer Research, 29(21), 4399–4407. https://doi.org/10.1158/1078-0432.ccr-23-1295

Wen, P. Y., van den Bent, M., Youssef, G., Cloughesy, T. F., Ellingson, B. M., Weller, M., Galanis, E., Barboriak, D. P., de Groot, J., Gilbert, M. R., Huang, R., Lassman, A. B., Mehta, M., Molinaro, A. M., Preusser, M., Rahman, R., Shankar, L. K., Stupp, R., Villanueva-Meyer, J. E., … Chang, S. M. (2023). RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. Journal of Clinical Oncology, 41(33), 5187–5199. https://doi.org/10.1200/jco.23.01059

Berkley, A., Saueressig, C., Shukla, U., Chowdhury, I., Munoz‐Gauna, A., Shehu, O., Singh, R., & Munbodh, R. (2023). Clinical capability of modern brain tumor segmentation models. Medical Physics, 50(8), 4943–4959. Portico. https://doi.org/10.1002/mp.16321

Upadhyayula, P. S., Neira, J. A., Miller, M. L., & Bruce, J. N. (2023). Benign and Malignant Tumors of the Pineal Region. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2, 153–173. https://doi.org/10.1007/978-3-031-23705-8_6

Wu, P. B., Filley, A. C., Miller, M. L., & Bruce, J. N. (2023). Benign Glioma. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2, 31–71. https://doi.org/10.1007/978-3-031-23705-8_2

Wang, L. M., Englander, Z. K., Miller, M. L., & Bruce, J. N. (2023). Malignant Glioma. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2, 1–30. https://doi.org/10.1007/978-3-031-23705-8_1

Kinslow, C. J., Mercurio, A., Kumar, P., Rae, A. I., Siegelin, M. D., Grinband, J., Taparra, K., Upadhyayula, P. S., McKhann, G. M., Sisti, M. B., Bruce, J. N., Canoll, P. D., Iwamoto, F. M., Kachnic, L. A., Yu, J. B., Cheng, S. K., & Wang, T. J. C. (2023). Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy. JAMA Oncology, 9(7), 919. https://doi.org/10.1001/jamaoncol.2023.0990

Ramkissoon, S. H., Fernandes, H., Lopez-Terrada, D. H., Hameed, M. R., Trembath, D. G., Bridge, J. A., Lindeman, N. I., Souers, R. J., Vasalos, P., Brat, D. J., & Moncur, J. T. (2022). Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors. Archives of Pathology & Laboratory Medicine, 147(5), 518–524. https://doi.org/10.5858/arpa.2021-0431-cp

Alkazemi, M., Lo, Y. T., Hussein, H., Mammi, M., Saleh, S., Araujo-Lama, L., Mommsen, S., Pisano, A., Lamba, N., Bunevicius, A., & Mekary, R. A. (2023). Laser Interstitial Thermal Therapy for the Treatment of Primary and Metastatic Brain Tumors: A Systematic Review and Meta-Analysis. World Neurosurgery, 171, e654–e671. https://doi.org/10.1016/j.wneu.2022.12.079

Rudà, R., Capper, D., Waldman, A. D., Pallud, J., Minniti, G., Kaley, T. J., Bouffet, E., Tabatabai, G., Aronica, E., Jakola, A. S., Pfister, S. M., Schiff, D., Lassman, A. B., Solomon, D. A., Soffietti, R., Weller, M., Preusser, M., Idbaih, A., Wen, P. Y., & van den Bent, M. J. (2022). EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors. Neuro-Oncology, 24(12), 2015–2034. https://doi.org/10.1093/neuonc/noac188

Argenziano, M. G., Furnari, J. L., Miller, M. L., Sun, Y., Banu, M. A., Neira, J. A., Snuderl, M., Bruce, J. N., Welch, M., McCormick, P., & Canoll, P. (2022). Thoracic low grade glial neoplasm with concurrent H3 K27M and PTPN11 mutations. Acta Neuropathologica Communications, 10(1). https://doi.org/10.1186/s40478-022-01340-9

Spinazzi, E. F., Argenziano, M. G., Upadhyayula, P. S., Banu, M. A., Neira, J. A., Higgins, D. M. O., Wu, P. B., Pereira, B., Mahajan, A., Humala, N., Al-Dalahmah, O., Zhao, W., Save, A. V., Gill, B. J. A., Boyett, D. M., Marie, T., Furnari, J. L., Sudhakar, T. D., Stopka, S. A., … Bruce, J. N. (2022). Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial. The Lancet Oncology, 23(11), 1409–1418. https://doi.org/10.1016/s1470-2045(22)00599-x

Miller, A. M., Szalontay, L., Bouvier, N., Hill, K., Ahmad, H., Rafailov, J., Lee, A. J., Rodriguez-Sanchez, M. I., Yildirim, O., Patel, A., Bale, T. A., Benhamida, J. K., Benayed, R., Arcila, M. E., Donzelli, M., Dunkel, I. J., Gilheeney, S. W., Khakoo, Y., Kramer, K., … Karajannis, M. A. (2022). Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients. Neuro-Oncology, 24(10), 1763–1772. https://doi.org/10.1093/neuonc/noac035

Gill, B. J. A., Khan, F. A., Goldberg, A. R., Merricks, E. M., Wu, X., Sosunov, A. A., Sudhakar, T. D., Dovas, A., Lado, W., Michalak, A. J., Teoh, J. J., Liou, J., Frankel, W. N., McKhann, G. M., Canoll, P., & Schevon, C. A. (2022). Single unit analysis and wide-field imaging reveal alterations in excitatory and inhibitory neurons in glioma. Brain, 145(10), 3666–3680. https://doi.org/10.1093/brain/awac168

Varn, F. S., Johnson, K. C., Martinek, J., Huse, J. T., Nasrallah, M. P., Wesseling, P., Cooper, L. A. D., Malta, T. M., Wade, T. E., Sabedot, T. S., Brat, D., Gould, P. V., Wöehrer, A., Aldape, K., Ismail, A., Sivajothi, S. K., Barthel, F. P., Kim, H., Kocakavuk, E., … Verhaak, R. GW. (2022). Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell, 185(12), 2184-2199.e16. https://doi.org/10.1016/j.cell.2022.04.038

Lassman, A. B., Sepúlveda-Sánchez, J. M., Cloughesy, T. F., Gil-Gil, M. J., Puduvalli, V. K., Raizer, J. J., De Vos, F. Y. F., Wen, P. Y., Butowski, N. A., Clement, P. M. J., Groves, M. D., Belda-Iniesta, C., Giglio, P., Soifer, H. S., Rowsey, S., Xu, C., Avogadri, F., Wei, G., Moran, S., & Roth, P. (2022). Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clinical Cancer Research, 28(11), 2270–2277. https://doi.org/10.1158/1078-0432.ccr-21-2664

Brat, D. J., Aldape, K., Bridge, J. A., Canoll, P., Colman, H., Hameed, M. R., Harris, B. T., Hattab, E. M., Huse, J. T., Jenkins, R. B., Lopez-Terrada, D. H., McDonald, W. C., Rodriguez, F. J., Souter, L. H., Colasacco, C., Thomas, N. E., Yount, M. H., van den Bent, M. J., & Perry, A. (2022). Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. Archives of Pathology & Laboratory Medicine, 146(5), 547–574. https://doi.org/10.5858/arpa.2021-0295-cp

Tom, M. C., Milano, M. T., Chao, S. T., Soltys, S. G., Knisely, J. P. S., Sahgal, A., Nagpal, S., Lo, S. S., Jabbari, S., Wang, T. J. C., Ahluwalia, M. S., Simonson, M., Palmer, J. D., Gephart, M. H., Halasz, L. M., Garg, A. K., Chiang, V. L. S., & Chang, E. L. (2022). Executive summary of American Radium Society’s appropriate use criteria for the postoperative management of lower grade gliomas. Radiotherapy and Oncology, 170, 79–88. https://doi.org/10.1016/j.radonc.2022.03.018